What's new in stroke? The top 10 studies of 2009-2011: part II

Robert G Hart1, Wiesław J Oczkowski

  • 1Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, United States. hartr@uthscsa.edu

Insights

Novel anticoagulants like dabigatran and apixaban show promise for preventing strokes in atrial fibrillation (AF) patients. Carotid stenting risks vary by age compared to endarterectomy, requiring further long-term outcome analysis.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Surgery

Background:

  • Atrial fibrillation (AF) and cervical carotid artery stenosis are significant risk factors for stroke.
  • Optimizing stroke prevention strategies is crucial for patient outcomes.

Purpose of the Study:

  • To review recent evidence on stroke prevention in patients with AF and cervical carotid artery stenosis.
  • To evaluate the efficacy and safety of novel oral anticoagulants and antiplatelet therapies for AF stroke prevention.
  • To compare the risks of carotid artery stenting versus endarterectomy.

Main Methods:

  • Review of five key studies published between 2009 and 2011.
  • Analysis of two large phase III randomized trials (RE-LY, AVERROES) on novel oral anticoagulants in AF.
  • Evaluation of one trial (ACTIVE A) on dual antiplatelet therapy in AF.
  • Assessment of two large randomized trials (CREST, ICSS) comparing carotid stenting and endarterectomy.

Main Results:

  • Dabigatran was superior to warfarin for stroke prevention in AF; apixaban was superior to aspirin in warfarin-ineligible patients. Major bleeding rates were similar for novel anticoagulants.
  • Dual antiplatelet therapy (clopidogrel plus aspirin) improved stroke prevention in AF but increased major bleeding.
  • Carotid stenting showed higher periprocedural stroke rates than endarterectomy, particularly in patients over 70.

Conclusions:

  • Novel oral anticoagulants offer effective stroke prevention for AF patients with acceptable bleeding risk.
  • Dual antiplatelet therapy may be considered for select AF patients but carries increased bleeding risks.
  • Carotid stenting and endarterectomy have comparable short-term risks in younger patients, but long-term data are needed for definitive comparison, especially for older individuals.

Related Concept Videos

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...